HAS2 and cancer: Furthermore, as is corroborated by the in vitro study showing that cancer-derived YAP regulates HAS2 in HSCs (Figure 4F), silencing Yap1 in cancer cells reduced Has2 expression in the CAF2 cluster (Figure 5G).